MedTrace Logo

Active Surveillance Post-Approval Atudy of the Stelkast Surpass Acetabular System

NCT01672086 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 347

Last updated 2016-10-13

No results posted yet for this study

Summary

The active surveillance post-approval study of the Stelkast Surpass Acetabular System is a retrospective, multi-center, single-arm study intended to collect data on the survivorship and long-term safety and effectiveness of the device.

Conditions

  • Survivorship and Long-term Safety and Effectiveness of the Stelkast Surpass Acetabular System

Interventions

DEVICE

Stelkast Surpass Acetabular System implant

Sponsors & Collaborators

  • StelKast, Inc.

    lead INDUSTRY

Principal Investigators

  • Abigail Allen · MCRA

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01672086 on ClinicalTrials.gov